BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19322615)

  • 1. Intramucosal esophageal cancer and high-grade dysplasia: which treatment frame the debate.
    Oelschlager BK
    J Gastrointest Surg; 2009 Jul; 13(7):1169-71. PubMed ID: 19322615
    [No Abstract]   [Full Text] [Related]  

  • 2. SSAT controversies intramucosal esophageal cancer and high-grade dysplasia: which treatment? Surgical therapy: improved outcomes and piece of mind.
    Peters JH
    J Gastrointest Surg; 2009 Jul; 13(7):1179-81. PubMed ID: 19294473
    [No Abstract]   [Full Text] [Related]  

  • 3. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 4. Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma.
    Schembre DB
    J Gastrointest Surg; 2009 Jul; 13(7):1172-8. PubMed ID: 19322616
    [No Abstract]   [Full Text] [Related]  

  • 5. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
    Reed CC; Shaheen NJ
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):768-772. PubMed ID: 27541732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma.
    Scotiniotis IA; Kochman ML; Lewis JD; Furth EE; Rosato EF; Ginsberg GG
    Gastrointest Endosc; 2001 Dec; 54(6):689-96. PubMed ID: 11726843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
    Kim MP; Brown KN; Schwartz MR; Blackmon SH
    Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
    Lewis JT; Wang KK; Abraham SC
    Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
    Pech O; Ell C
    Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of invasive cancer after endoscopic treatment of Barrett's esophagus with high-grade dysplasia and intramucosal cancer in physiologically fit patients: time for a review of surveillance and treatment guidelines.
    Templeton A; Bodnar A; Gan SI; Irani S; Ross A; Low D
    Gastrointest Endosc; 2014 May; 79(5):839-44. PubMed ID: 24447341
    [No Abstract]   [Full Text] [Related]  

  • 16. Endoscopic work-up of early Barrett's neoplasia.
    Curvers WL; Bansal A; Sharma P; Bergman JJ
    Endoscopy; 2008 Dec; 40(12):1000-7. PubMed ID: 19065483
    [No Abstract]   [Full Text] [Related]  

  • 17. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
    Luna RA; Gilbert E; Hunter JG
    Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive esophagectomy.
    Gilbert S; Luketich JD
    Adv Surg; 2004; 38():67-83. PubMed ID: 15515615
    [No Abstract]   [Full Text] [Related]  

  • 20. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F; Harewood GC; Patchett SE
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.